rs17882828
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000212355.9(TGFBR3):āc.2293G>Cā(p.Gly765Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00398 in 1,613,652 control chromosomes in the GnomAD database, including 52 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000212355.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFBR3 | NM_003243.5 | c.2293G>C | p.Gly765Arg | missense_variant | 15/17 | ENST00000212355.9 | NP_003234.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFBR3 | ENST00000212355.9 | c.2293G>C | p.Gly765Arg | missense_variant | 15/17 | 1 | NM_003243.5 | ENSP00000212355 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00403 AC: 613AN: 152114Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00711 AC: 1787AN: 251370Hom.: 14 AF XY: 0.00643 AC XY: 873AN XY: 135860
GnomAD4 exome AF: 0.00397 AC: 5800AN: 1461420Hom.: 46 Cov.: 30 AF XY: 0.00389 AC XY: 2826AN XY: 727020
GnomAD4 genome AF: 0.00405 AC: 617AN: 152232Hom.: 6 Cov.: 32 AF XY: 0.00457 AC XY: 340AN XY: 74418
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
TGFBR3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at